🏛️ Verified NIH Record • Updated 2026-05-04
A Phase 1 Clinical Trial of Adjuvanted Protein-based HCV Vaccine Candidates (HCV Vaccine Trial) (NCT07237282)
🟡 Not Yet Recruiting Phase1 💊 Investigational Drug / Biologic Sponsor: University of Alberta
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to investigate the safety and antibody (germ fighters) response of the experimental (investigational) vaccine against HCV when injected into the arm of healthy adults.
Who can join: Review the eligibility criteria below.
Location: University of Alberta Hospital — Edmonton, Alberta
Age range: 18 Years to 45 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (3 Sites)
- University of Alberta Hospital — Edmonton, Alberta
- Ottawa Hospital - General Campus — Ottawa, Ontario
- Toronto General Hospital - Toronto Centre for Liver Disease — Toronto, Ontario
📞 Contact the Study Coordinator
Phone: (587) 598-2336
Email: hcv@ualberta.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Hepatitis C
- DBS TaT in Peer-assisted Telemedicine for Hepatitis C — Portland, Oregon
- A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients — Phoenix, Arizona
- Advanced Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants — Greenville, South Carolina
- ED Patient's Perceptions and Acceptability Toward a Novel POC HCV Viral Load Testing — Baltimore, Maryland
- Use of a Patient-Centered Electronic App to Increase ED Patient's Knowledge on HCV to Improve the HCV Care Continuum — Baltimore, Maryland
Explore by condition: All Hepatitis C clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.